基立福(GRFS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GRFS 基立福

交易中 11-05 12:39:03 EST

9.14

+0.34

+3.86%

最高9.24	最低8.69	成交量63.88万
今开8.74	昨收8.80	日振幅6.20%
总市值62.12亿	流通市值50.08亿	总股本6.80亿
成交额572.50万	换手率0.12%	流通股本5.48亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GRFS","market":"US","secType":"STK","nameCN":"基立福","latestPrice":9.14,"timestamp":1730828334298,"preClose":8.8,"halted":0,"volume":638772,"delay":0,"floatShares":547935885,"shares":679629199,"eps":0.23825,"marketStatus":"交易中","marketStatusCode":2,"change":0.34,"latestTime":"11-05 12:39:03 EST","open":8.74,"high":9.24,"low":8.6943,"amount":5724962.111400001,"amplitude":0.062011,"askPrice":9.15,"askSize":200,"bidPrice":9.14,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.23825,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1730840400000},"adr":1,"listingDate":1320120000000,"adjPreClose":8.8,"adrRate":1,"dividendRate":0.043665,"preHourTrading":{"tag":"盘前","latestPrice":8.75,"preClose":8.8,"latestTime":"09:06 EST","volume":2476,"amount":21689.519828,"timestamp":1730815575954},"postHourTrading":{"tag":"盘后","latestPrice":8.8,"preClose":8.8,"latestTime":"16:01 EST","volume":1910,"amount":16808,"timestamp":1730754110246},"volumeRatio":1.211552,"impliedVol":1.123,"impliedVolPercentile":0.8651},"requestUrl":"/m/hq/s/GRFS","defaultTab":"news","newsList":[{"id":"2479339781","title":"基立福盘中异动 早盘大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479339781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479339781?lang=zh_cn&edition=full","pubTime":"2024-10-30 22:14","pubTimestamp":1730297642,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日22时14分，基立福股票出现异动，股价急速上涨5.00%。截至发稿，该股报8.61美元/股，成交量29.4735万股，换手率0.04%，振幅2.62%。基立福股票所在的制药行业中，整体跌幅为5.89%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030221402971a340e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030221402971a340e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":1},{"id":"2470626094","title":"基立福盘中异动 股价大跌5.29%报8.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470626094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470626094?lang=zh_cn&edition=full","pubTime":"2024-09-26 00:05","pubTimestamp":1727280339,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日00时05分，基立福股票出现异动，股价急速跳水5.29%。截至发稿，该股报8.24美元/股，成交量78.0398万股，换手率0.11%，振幅5.40%。基立福股票所在的制药行业中，整体跌幅为0.29%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926000539a1dc7e41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926000539a1dc7e41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"2459390027","title":"基立福盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459390027","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459390027?lang=zh_cn&edition=full","pubTime":"2024-08-13 22:30","pubTimestamp":1723559434,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日22时30分，基立福股票出现波动，股价大幅跳水5.01%。截至发稿，该股报6.82美元/股，成交量33.9492万股，换手率0.05%，振幅2.86%。基立福股票所在的制药行业中，整体涨幅为1.54%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081322303597198a96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081322303597198a96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2457523825","title":"基立福盘中异动 早盘股价大涨5.11%报7.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457523825","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457523825?lang=zh_cn&edition=full","pubTime":"2024-08-07 23:24","pubTimestamp":1723044244,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日23时24分，基立福股票出现波动，股价快速上涨5.11%。截至发稿，该股报7.61美元/股，成交量50.7494万股，换手率0.07%，振幅2.90%。基立福股票所在的制药行业中，整体跌幅为0.92%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807232405941ff136&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807232405941ff136&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":1},{"id":"2457705712","title":"基立福盘中异动 下午盘股价大跌5.01%报7.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457705712","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457705712?lang=zh_cn&edition=full","pubTime":"2024-08-06 01:00","pubTimestamp":1722877211,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日01时00分，基立福股票出现异动，股价快速下跌5.01%。截至发稿，该股报7.20美元/股，成交量70.4217万股，换手率0.10%，振幅3.76%。基立福股票所在的制药行业中，整体跌幅为3.10%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080601001296823ff0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080601001296823ff0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2456022198","title":"基立福2024财年第二财季实现净利润15.98百万美元，同比减少71.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456022198","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456022198?lang=zh_cn&edition=full","pubTime":"2024-08-04 00:16","pubTimestamp":1722701799,"startTime":"0","endTime":"0","summary":"8月4日，基立福公布财报，公告显示公司2024财年第二财季净利润为15.98百万美元，同比减少71.79%；其中营业收入为19.57亿美元，同比增加8.12%，每股基本收益为0.02美元。从资产负债表来看，基立福总负债149.86亿美元，其中短期债务28.70亿美元，资产负债比为1.60，流动比率为1.69。机构评级：截至2024年8月4日，当前有1家机构对基立福目标价做出预测，其中目标均价为11.13美元，其中最低目标价为11.13美元，最高目标价为11.13美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240804001649957ab1b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240804001649957ab1b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GRFS"],"gpt_icon":0},{"id":"2455959527","title":"基立福（GFR.SM）下跌2%，此前西班牙证券监管部门CNMV取消（在披露相关信息期间的）交易暂停措施。","url":"https://stock-news.laohu8.com/highlight/detail?id=2455959527","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455959527?lang=zh_cn&edition=full","pubTime":"2024-07-30 22:56","pubTimestamp":1722351382,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/us-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/us-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["GRFS","BK4139","161027"],"gpt_icon":0},{"id":"2455893000","title":"基立福盘中异动 早盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455893000","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455893000?lang=zh_cn&edition=full","pubTime":"2024-07-30 21:37","pubTimestamp":1722346660,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日21时37分，基立福股票出现异动，股价大幅下跌5.19%。截至发稿，该股报7.31美元/股，成交量25.0458万股，换手率0.04%，振幅2.92%。基立福股票所在的制药行业中，整体涨幅为0.36%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730213740968219c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730213740968219c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2451655147","title":"基立福盘中异动 下午盘快速下挫5.08%报8.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451655147","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451655147?lang=zh_cn&edition=full","pubTime":"2024-07-13 01:58","pubTimestamp":1720807094,"startTime":"0","endTime":"0","summary":"北京时间2024年07月13日01时58分，基立福股票出现波动，股价大幅下跌5.08%。截至发稿，该股报8.40美元/股，成交量208.638万股，换手率0.31%，振幅6.10%。基立福股票所在的制药行业中，整体涨幅为1.17%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240713015814af9221ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240713015814af9221ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2451155535","title":"基立福 - 在交易背景下委派交易委员会工作以吸引财务顾问","url":"https://stock-news.laohu8.com/highlight/detail?id=2451155535","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451155535?lang=zh_cn&edition=full","pubTime":"2024-07-13 00:41","pubTimestamp":1720802506,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"2451555352","title":"基立福 - 关于可能与布鲁克菲尔德进行的交易将设立由独立董事组成的董事会委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=2451555352","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451555352?lang=zh_cn&edition=full","pubTime":"2024-07-13 00:40","pubTimestamp":1720802452,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BRKR","GRFS","BK4139","BK4121","LU0757428866.USD","LU1815336091.USD"],"gpt_icon":0},{"id":"2450184668","title":"基立福盘中异动 早盘快速上涨6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450184668","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450184668?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:33","pubTimestamp":1720618382,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时33分，基立福股票出现波动，股价急速上涨6.03%。截至发稿，该股报8.88美元/股，成交量29.3441万股，换手率0.04%，振幅1.55%。基立福股票所在的制药行业中，整体涨幅为0.18%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213302959f0951&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710213302959f0951&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2449970113","title":"成分股Morphic Holdings Inc.目前涨超75%，基立福ADR涨超19.3%，Ideaya Biosciences涨约14.","url":"https://stock-news.laohu8.com/highlight/detail?id=2449970113","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449970113?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:52","pubTimestamp":1720450341,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["00013","BK4588","BK1191","BK4585","GRFS","BK1588","HCM","BK4139","BK4531","BK4007","BK1587"],"gpt_icon":0},{"id":"2449765703","title":"基立福盘中异动 急速拉升20.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449765703","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449765703?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:31","pubTimestamp":1720445511,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日21时31分，基立福股票出现异动，股价快速上涨20.45%。基立福股票所在的制药行业中，整体涨幅为0.17%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082131519f1ee7c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082131519f1ee7c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2449744544","title":"西班牙证券监管机构暂停化学及制药公司基立福（Grifols）的交易。消息称Grifols家族和加拿大基金Brookfield正在商谈对西班牙制药商Grifols发起收购收购价值可能在55亿欧元（59.","url":"https://stock-news.laohu8.com/highlight/detail?id=2449744544","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449744544?lang=zh_cn&edition=full","pubTime":"2024-07-08 14:59","pubTimestamp":1720421950,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01477","BN","BK4588","BK1574","BK1191","BK4585","EUO","BK4135","MEURmain","GRFS","IE00B3S45H60.SGD","FXE","IE00B775SV38.USD","BK4139","EURmain"],"gpt_icon":0},{"id":"2449744548","title":"西班牙证券监管机构暂停化学及制药公司基立福（Grifols）的交易。消息称Grifols家族和加拿大基金Brookfield正在商谈对西班牙制药商Grifols发起收购，收购价值可能在55亿欧元（59.","url":"https://stock-news.laohu8.com/highlight/detail?id=2449744548","media":"汇通网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449744548?lang=zh_cn&edition=full","pubTime":"2024-07-08 14:58","pubTimestamp":1720421928,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://kx.fx678.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_huitong","symbols":["GRFS","BK4588","EURmain","BK1191","FXE","IE00B775SV38.USD","BN","EUO","BK4139","IE00B3S45H60.SGD","BK1574","BK4585","01477","MEURmain","BK4135"],"gpt_icon":0},{"id":"2449810298","title":"基立福盘中异动 早盘快速拉升5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449810298","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449810298?lang=zh_cn&edition=full","pubTime":"2024-07-05 21:31","pubTimestamp":1720186268,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日21时31分，基立福股票出现异动，股价快速上涨5.57%。截至发稿，该股报7.01美元/股，成交量4.3245万股，换手率0.01%，振幅0.30%。基立福股票所在的制药行业中，整体涨幅为0.13%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407052131099f0acdd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407052131099f0acdd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2446506553","title":"基立福股价重挫11.62% 市值跌4.86亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446506553","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446506553?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:31","pubTimestamp":1719495115,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时31分，基立福股票出现波动，股价快速跳水11.62%。截至发稿，该股报6.16美元/股，成交量23.9232万股，换手率0.04%，振幅1.00%。基立福股票所在的制药行业中，整体涨幅为0.00%。通过 2011 年收购 Talecris，基立福极大地扩展了其血浆衍生产品组合，继该公司于 2022 年 4 月收购 Biotest 后，生物制药业务贡献了 2023 年销售额的 84%。基立福还拥有较小的业务分部，包括诊断业务 和生物供应业务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721315595de72b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721315595de72b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GRFS"],"gpt_icon":0},{"id":"2444269067","title":"研报掘金丨中邮证券：上海莱士股权转让正式落地，公司开启新征程中邮证券研报指出，上海莱士(002252.SZ)股权转让正式落地，海尔赋能长期发展，公司开启新征程。","url":"https://stock-news.laohu8.com/highlight/detail?id=2444269067","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444269067?lang=zh_cn&edition=full","pubTime":"2024-06-20 15:53","pubTimestamp":1718870017,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4139","002252","BK0239","BK0046","BK0188","01169","161027","GRFS","BK0196","BK0028"],"gpt_icon":0},{"id":"2444737269","title":"上海莱士(002252)：股权转让正式落地 海尔赋能长期发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2444737269","media":"中邮证券有限责...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444737269?lang=zh_cn&edition=full","pubTime":"2024-06-20 00:00","pubTimestamp":1718812800,"startTime":"0","endTime":"0","summary":"海盈康持有公司20%的股份并通过海盈康合计控制公司26.58%股份所对应的表决权，成为公司控股股东，海尔集团将成为公司实际控制人。股权转让正式落地，公司开启新征程：2023 年12 月29 日，上海莱士与基立福签署《战略合作及股份购买协议》，海尔集团或其指定关联方拟协议收购基立福持有的公司13.29 亿股股份，占公司总股本的20.00%，转让价款125 亿元人民币。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406201549539f51a55d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406201549539f51a55d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2097828474.EUR","BK0224","LU2097828557.USD","BK0015","SGXZ49509284.SGD","600690","BK0239","LU1064130708.USD","LU1064131003.USD","BK0026","BK0187","BK0046","LU2097828805.USD","BK0175","LU2148510915.USD","002252","BK0183","BK0201","BK0188","BK0196","BK0012","GRFS","SGXZ81163826.USD","BK0130","LU2097828714.EUR","BK0028","LU2097828631.EUR","BK0067"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.grifols.com","stockEarnings":[{"period":"1week","weight":0.0552},{"period":"1month","weight":-0.0135},{"period":"3month","weight":0.2155},{"period":"6month","weight":0.2865},{"period":"1year","weight":-0.0548},{"period":"ytd","weight":-0.2388}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GRIFOLS, S.A.由Jose Antonio Grifols i Roig先生于1940年在西班牙巴塞罗那创建成立，公司是全球主要生物制药企业。公司业务涉及血浆系列产品的研发，生产和大范围销售。Grifols股份有限公司的商业活动包括原材料分类、生产各类型血浆提取产品以及将最终产出售并配送给保健品提供商。","yearOnYearQuotes":[{"month":1,"riseRate":0.692308,"avgChangeRate":0.006684},{"month":2,"riseRate":0.538462,"avgChangeRate":0.001444},{"month":3,"riseRate":0.461538,"avgChangeRate":-0.010634},{"month":4,"riseRate":0.538462,"avgChangeRate":0.020123},{"month":5,"riseRate":0.461538,"avgChangeRate":0.012333},{"month":6,"riseRate":0.461538,"avgChangeRate":0.019747},{"month":7,"riseRate":0.642857,"avgChangeRate":0.021434},{"month":8,"riseRate":0.214286,"avgChangeRate":-0.037926},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.021077},{"month":10,"riseRate":0.5,"avgChangeRate":0.002945},{"month":11,"riseRate":0.571429,"avgChangeRate":0.03563},{"month":12,"riseRate":0.692308,"avgChangeRate":0.028882}],"exchange":"NASDAQ","name":"基立福","nameEN":"Grifols SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"基立福(GRFS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供基立福(GRFS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"基立福,GRFS,基立福股票,基立福股票老虎,基立福股票老虎国际,基立福行情,基立福股票行情,基立福股价,基立福股市,基立福股票价格,基立福股票交易,基立福股票购买,基立福股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"基立福(GRFS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供基立福(GRFS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}